Embryonic Stem Cell Patents and Human Dignity

Health Care Analysis 15 (3):211-222 (2007)
  Copy   BIBTEX

Abstract

This article examines the assertion that human embryonic stem cells patents are immoral because they violate human dignity. After analyzing the concept of human dignity and its role in bioethics debates, this article argues that patents on human embryos or totipotent embryonic stem cells violate human dignity, but that patents on pluripotent or multipotent stem cells do not. Since patents on pluripotent or multipotent stem cells may still threaten human dignity by encouraging people to treat embryos as property, patent agencies should carefully monitor and control these patents to ensure that patents are not inadvertently awarded on embryos or totipotent stem cells

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,386

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Moral complicity in induced pluripotent stem cell research.Mark T. Brown - 2009 - Kennedy Institute of Ethics Journal 19 (1):pp. 1-22.
Stem cell research: An ethical evaluation of policy options.Nikolaus Knoepffler - 2004 - Kennedy Institute of Ethics Journal 14 (1):55-74.
Embryonic Stem Cells and Property Rights.A. -K. M. Andersson - 2011 - Journal of Medicine and Philosophy 36 (3):221-242.

Analytics

Added to PP
2013-11-24

Downloads
61 (#259,066)

6 months
11 (#225,837)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

References found in this work

In defense of posthuman dignity.Nick Bostrom - 2005 - Bioethics 19 (3):202–214.
The Varieties of Dignity.Lennart Nordenfelt - 2004 - Health Care Analysis 12 (2):69-81.

View all 22 references / Add more references